These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2113644)

  • 21. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of glucose intake on urine saturation with calcium oxalate, calcium phosphate, uric acid and sodium urate.
    Głuszek J
    Int Urol Nephrol; 1988; 20(6):657-64. PubMed ID: 3229936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine composition and stone formation during treatment with acetazolamide.
    Ahlstrand C; Tiselius HG
    Scand J Urol Nephrol; 1987; 21(3):225-8. PubMed ID: 3433023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M; Genestar C; Palou A; Pons A; Conte A; Grases F
    Int Urol Nephrol; 1989; 21(3):281-8. PubMed ID: 2807779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiological role of estrogen status in renal stone formation.
    Heller HJ; Sakhaee K; Moe OW; Pak CY
    J Urol; 2002 Nov; 168(5):1923-7. PubMed ID: 12394677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique.
    Fan J; Chandhoke PS
    J Urol; 1999 May; 161(5):1685-8. PubMed ID: 10210440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate.
    Pak CY; Rodgers K; Poindexter JR; Sakhaee K
    J Urol; 2008 Oct; 180(4):1532-7. PubMed ID: 18710766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythms of urinary saturation levels of calcium oxalate and calcium phosphate in normal male individuals.
    Ogawa Y
    Hinyokika Kiyo; 1993 Sep; 39(9):785-9. PubMed ID: 8213370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
    Atmani F; Khan SR
    Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
    Prochaska M; Taylor E; Ferraro PM; Curhan G
    J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Michalenka AC; Strutz KL; Donahue S; Asplin JR
    Kidney Int; 2008 Feb; 73(4):423-9. PubMed ID: 18046318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.